loadpatents
name:-0.021894931793213
name:-0.014368057250977
name:-0.00059413909912109
MAZUROV; Anatoly Patent Filings

MAZUROV; Anatoly

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAZUROV; Anatoly.The latest application filed is for "3-(1,2,3,6-tetrahydropyridin-2-yl) pyridine glutarate or a pharmaceutically acceptable solvate thereof".

Company Profile
0.14.21
  • MAZUROV; Anatoly - Greensboro Guilford NC
  • Mazurov; Anatoly - Greensboro NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
3-(1,2,3,6-tetrahydropyridin-2-yl) Pyridine Glutarate Or A Pharmaceutically Acceptable Solvate Thereof
App 20210395218 - MAZUROV; Anatoly
2021-12-23
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide
App 20170119746 - Bencherif; Merouane ;   et al.
2017-05-04
Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
Grant 9,580,434 - Mazurov , et al. February 28, 2
2017-02-28
Nicotinic Acetylcholine Receptor Sub-type Selective Amides Of Diazabicycloalkanes
App 20160039833 - Mazurov; Anatoly ;   et al.
2016-02-11
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- robenzamide
Grant 9,173,876 - Bencherif , et al. November 3, 2
2015-11-03
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide
App 20150105421 - Bencherif; Merouane ;   et al.
2015-04-16
Sub-type Selective Amides Of Diazabicycloalkanes
App 20150080576 - Mazurov; Anatoly ;   et al.
2015-03-19
Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
Grant 8,921,410 - Mazurov , et al. December 30, 2
2014-12-30
Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobe- nzamide
Grant 8,901,151 - Bencherif , et al. December 2, 2
2014-12-02
Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
Grant 8,859,609 - Mazurov , et al. October 14, 2
2014-10-14
1,4-diazabicyclo[3.2.2]nonanes As Neuronal Nicotinic Acetylcholine Receptor Ligands
App 20140249141 - Mazurov; Anatoly ;   et al.
2014-09-04
Preparation And Therapeutic Applications Of (2s, 3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobe- Nzamide
App 20140163065 - Bencherif; Merouane ;   et al.
2014-06-12
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluo- robenzamide
Grant 8,476,296 - Bencherif , et al. July 2, 2
2013-07-02
Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes
App 20130005789 - Mazurov; Anatoly ;   et al.
2013-01-03
Nicotinic Acetylcholine Receptor Sub-Type Selective Amides of Diazabicycloalkanes
App 20120289572 - Mazurov; Anatoly ;   et al.
2012-11-15
Sub-type selective azabicycloalkane derivatives
Grant 8,198,296 - Hammond , et al. June 12, 2
2012-06-12
Fused Benzoazepines As Neuronal Nicotinic Acetylcholine Receptor Ligands
App 20120053168 - Bhatti; Balwinder Singh ;   et al.
2012-03-01
Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
Grant 8,114,889 - Mazurov , et al. February 14, 2
2012-02-14
Amides Of Diazabicyclooctanes And Uses Thereof
App 20110263629 - Strachan; Jon-Paul ;   et al.
2011-10-27
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide
App 20110257224 - Bencherif; Merouane ;   et al.
2011-10-20
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
Grant 7,897,611 - Bhatti , et al. March 1, 2
2011-03-01
Heteroaryl-substituted Diazatricycloalkanes And Methods Of Use Thereof
App 20100197720 - Mazurov; Anatoly ;   et al.
2010-08-05
Sub-type Selective Azabicycloalkane Derivatives
App 20100173968 - Hammond; Philip S. ;   et al.
2010-07-08
Sub-type Selective Amides Of Diazabicycloalkanes
App 20100173932 - Mazurov; Anatoly ;   et al.
2010-07-08
Pharmaceutical Compositions And Methods For Relieving Pain And Treating Central Nervous System Disorders
App 20100152228 - Breining; Scott R. ;   et al.
2010-06-17
Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
Grant 7,732,607 - Mazurov , et al. June 8, 2
2010-06-08
Nicotinic Acetylcholine Receptor Sub-type Selective Amides Of Diazabicycloalkanes
App 20100081683 - Mazurov; Anatoly ;   et al.
2010-04-01
Pharmaceutical Compositions and Methods for Relieving Pain and Treating Central Nervous System Disorders
App 20080242693 - Breining; Scott R. ;   et al.
2008-10-02
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
Grant 7,402,592 - Breining , et al. July 22, 2
2008-07-22
Heteroaryl-Substituted Diazatricycloalkanes and Methods of Use Thereof
App 20070197579 - Mazurov; Anatoly ;   et al.
2007-08-23
Pharmaceutical Compositions And Methods For Relieving Pain And Treating Central Nervous System Disorders
App 20050282823 - Breining, Scott R. ;   et al.
2005-12-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed